Fig. 7From: Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking studyMolecular docking simulation for the compounds of AGS binding the therapeutic targets of colorectal cancer. (a) Molecular docking simulation between 11-O-protocatechuoylbergenin and SRC, (b) molecular docking simulation between epicatechin-3-gallate and SRC, (c) molecular docking simulation between 11-O-galloylbergenin and MAPK1, (d) molecular docking simulation between epicatechin-3-gallate and MAPK1, (e) molecular docking simulation between bergenin and ESR1, (f) molecular docking simulation between epicatechin-3-gallate and ESR1, (g) molecular docking simulation between 11-O-protocatechuoylbergenin and HSP90AA1, (h) molecular docking simulation between 11-O-syringylbergenin and HSP90AA1, (i) molecular docking simulation between 11-O-galloylbergenin and MAPK8, (j) molecular docking simulation between 11-O-syringylbergenin and MAPK8Back to article page